CYAD

Celyad Oncology SA American Depositary Shares

Delisted

CYAD was delisted on the 18th of May, 2023.

10 hedge funds and large institutions have $24.2M invested in Celyad Oncology SA American Depositary Shares in 2021 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
10
Holders Change
+3
Holders Change %
+42.86%
% of All Funds
0.15%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
6
Increased
1
Reduced
3
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
FIG
1
Fortress Investment Group
New York
$23.8M +$23.8M +6,500,000 New
HF
2
HRT Financial
New York
$139K +$139K +38,105 New
Morgan Stanley
3
Morgan Stanley
New York
$88K -$3.17K -862 -3%
Wells Fargo
4
Wells Fargo
California
$69K +$40.2K +10,850 +139%
TSS
5
Two Sigma Securities
New York
$65K +$65K +17,786 New
Jane Street
6
Jane Street
New York
$44K +$44K +11,122 New
UBS Group
7
UBS Group
Switzerland
$13K -$2.95K -812 -18%
National Bank of Canada
8
National Bank of Canada
Quebec, Canada
$12K +$12K +3,400 New
Osaic Holdings
9
Osaic Holdings
Arizona
$6K -$1.52K -380 -20%
TRCT
10
Tower Research Capital (TRC)
New York
$4K +$4K +1,225 New
ECM
11
Endurant Capital Management
California
-$596K -145,380 Closed
JPMorgan Chase & Co
12
JPMorgan Chase & Co
New York
-$12K -3,000 Closed